葡甘聚糖对Caco-2细胞中二肽基肽酶Ⅳ抑制作用的研究

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (7): 754-758.

葡甘聚糖对Caco-2细胞中二肽基肽酶Ⅳ抑制作用的研究

孙娟, 葛声, 沈丽, 曹芸

上海交通大学附属第六人民医院临床营养科,上海 200233

收稿日期:2011-05-31 修回日期:2011-07-14 出版日期:2011-07-26 发布日期:2011-09-22
通讯作者: 葛声,女,博士,副主任医师,硕导,研究方向: 营养与代谢性疾病的防治。E-mail: gesheng607@126.com
作者简介:孙娟,女,硕士研究生,研究方向: 营养与代谢性疾病的防治。Tel: 15221528147 E-mail: sunjuan1218@yeah.net

Glucomannan inhibit dipeptidyl peptidase 4 (DPP4) activity in the Caco-2 cell

SUN Juan, GE Sheng, SHEN Li, CAO Yun

Department of Clinical Nutrition, Shanghai Jiaotong University Affiliated the Sixth People's Hospital, Shanghai 200233, China

Received:2011-05-31 Revised:2011-07-14 Online:2011-07-26 Published:2011-09-22

摘要/Abstract

摘要： 目的: 研究不同浓度葡甘聚糖作用长、短不同时间对Caco-2细胞中二肽基肽酶 Ⅳ(dipeptidyl peptidase 4, DPP4)的抑制作用。方法: 实验分为葡甘聚糖60、240 mg/L 两个低浓度梯度组,400、500 mg/L 两个中浓度梯度组,700、800、900 mg/L 3个高浓度梯度组,阴性对照组和空白对照组。各实验组分别单独作用于Caco-2细胞 12 h 和 36 h,采用以甘氨酰脯氨酸对硝基苯胺(Gly-Pro-pNA)为底物的发色底物法检测不同浓度葡甘聚糖对体外Caco-2细胞中DPP-Ⅳ活性的影响。结果: (1)低、中、高浓度梯度的葡甘聚糖短时间(12 h)作用于Caco-2细胞后,与阴性对照组相比较得到P值,低浓度梯度组分别为 0.579、0.545,中浓度梯度组分别为 0.349、0.080,高浓度梯度组分别为 0.082、0.097、0.429,差异均无统计学意义(P＞0.05)。(2)低、中、高浓度梯度的葡甘聚糖长时间(36 h)作用于Caco-2细胞后,与阴性对照组相比较得到P值,低浓度梯度组分别为 0.007、0.002,中浓度梯度组分别为 0.621、0.976,高浓度梯度组分别为 1.000、0.940、0.994,低浓度梯度组与阴性对照组相比较差异具有统计学意义(P＜0.05)。结论: 不同浓度葡甘聚糖短时间(12 h)作用于Caco-2细胞后,700 mg/L 的高浓度葡甘聚糖对Caco-2细胞中DPP-Ⅳ活性有一定的抑制作用趋势;长时间(36 h)作用于Caco-2细胞后,60、240 mg/L 的低浓度葡甘聚糖能够抑制Caco-2细胞中DPP-Ⅳ活性。

关键词: 葡甘聚糖, Caco-2细胞, 二肽基肽酶Ⅳ, 抑制作用

Abstract: AIM: To observe the inhibitory effect of different concentration of Glucomannan on dipeptidyl peptidase 4 activity in the Caco-2 cell at 12 h, 36 h, respectively.METHODS: Seven different concentrations were tested in this experiment, two low concentration groups (60, 240 mg/L), two middle concentration groups (400, 500 mg/L), three high concentration groups(700, 800, 900 mg/L) of Glucomannan, negative control group, and blank control group. Each treatment lasted for 12 hours and 36 hours respectively. DPP4 activity was measured with colorimetric determination of product formation (HGly-Pro-pNA, 0.2 mmol/L, Bachem) in different situations.RESULTS: (1) Compared with the negative control group, the P values of the different concentrations of glucomannan were 0.579, 0.545 (the low concentration groups), 0.349, 0.080 (the middle concentration groups), 0.082, 0.097, 0.429 (the high Concentrations groups) respectively after reacting with Caco-2 cells for a short of time. There were no significant differences detected. (2) At 36 h, the P values were 0.007, 0.002 (the low concentration groups), 0.621, 0.976 (the middle concentration groups), 1.000, 0.940, 0.994 (the high concentrations groups) respectively. The differences between the negative control groups and the low concentration groups have statistical significance (P＜0.05).CONCLUSION: There is a trend indicating that the high concentrations of glucomannan (700 mg/L) may inhibit the DPP4 activity in Caco-2 cells at 12 h. However, under the same circumstance, the low concentration of glucomannan (60, 240 mg/L) can inhibit the DPP4 activity in Caco-2 cells in a long term (36 h).

Key words: Glucomannan, Caco-2 cell, Dipeptidyl peptidase Ⅳ, Inhibitory effect

中图分类号:

R965.2

孙娟, 葛声, 沈丽, 曹芸. 葡甘聚糖对Caco-2细胞中二肽基肽酶Ⅳ抑制作用的研究[J]. 中国临床药理学与治疗学, 2011, 16(7): 754-758.

SUN Juan, GE Sheng, SHEN Li, CAO Yun. Glucomannan inhibit dipeptidyl peptidase 4 (DPP4) activity in the Caco-2 cell[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(7): 754-758.

参考文献

[1] Doi K. Effect of konjac fibre (glucomannan) on glucose and lipids[J]. Eur J Clin Nutr, 1995, 49(333): S190-197.
[2] Vuksan V, Sievenpiper JL, Owen R, et al. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial[J]. Diabetes Care, 2000, 23(1): 9-14.
[3] Yoshida M, Sawa J, Hozumi T, et al. Effects of long-term high-fiber diet on macrovascular changes and lipid and glucose levels in STZ-induced diabetic SD rats[J]. Diabetes Res Clin Pract, 1991, 13(3): 147-152.
[4] Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial[J]. Diabetes Care, 1999, 22(6): 913-919.
[5] Yoshida M, Vanstone CA, Parsons WD, et al. Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes[J]. Eur J Clin Nutr, 2006, 60(4): 529-537.
[6] 王小燕, 顾耀, 闵吻, 等. 葡甘聚糖对四氧嘧啶糖尿病模型大鼠的疗效观察[J]. 上海医学, 2005, 28(5): 406-411.
[7] 向明, 张晓煜, 伍三兰, 等. 魔芋葡甘聚糖对链脲霉素致大鼠糖尿病的防治作用[J]. 中国医院药学杂志, 2005, 25 (3): 223-225.
[8] Deacon CF. Therapeutic strategies based on glucagon-like peptide 1[J]. Diabetes, 2004, 53(9): 2181- 2189.
[9] 顿新鹏, 陈正望. 胰高血糖素样肽1及其修饰物的生理作用与临床应用[J]. 中华内分泌代谢杂志, 2005, 21(3): 288-291.
[10] Hansotia T, Drucker DJ. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice[J]. Regul Pept, 2005, 128(2): 125-134.
[11] Ahrén B, Landin-Olsson M, Jansson PA, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes[J]. J Clin Endocrinol Metab, 2004, 89(5): 2078-2084.
[12] González-Abuin N, Martiánez-Micaelo N, Blay M, et al. Grape-seed derived procyanidins inhibit dipeptidyl peptidase 4 (DPP4) activity[J]. FEBS J, 2010, 277: 62-63.
[13] 孔亮, 罗海吉, 卢晓翠, 等. MTT法测定不同铁浓度对体外Caco-2细胞生长的影响[J]. 微量元素与健康研究, 2006, 23(3): 4-5.
[14] 苗雷, 许泓瑜, 雷楗勇. 二肽基肽酶Ⅳ抑制剂体外筛选模型的建立及应用[J]. 中国药理学通报, 2009, 25(3): 411-414.